Viome partners with Microsoft to scale its RNA-based health platform, using AI and cloud computing to deliver personalized ...

A collaboration between Viome Life Sciences and Scripps Research is set to develop and clinically validate the first ribonucleic acid (RNA) test aimed at detecting precancerous colon polyps. This ...

Viome Life Sciences, the leader in AI-powered, RNA-based diagnostics and precision nutrition and  Scripps Research, the ...

Viome Life Sciences, a leader in AI-powered, RNA-based molecular diagnostics and personalized nutrition, today announced a ...

Viome Life Sciences, the leader in AI-powered, RNA-based diagnostics and precision nutrition and Scripps Research, the leader in accelerating the impact of fundamental research on human health, today ...

Microsoft Corporation (NASDAQ:MSFT) is one of the best US stocks to buy and hold in 2025. On July 7, Viome Life Sciences ...

Viome Life Sciences, a biotechnology company founded in 2016, has launched CancerDetect, a diagnostic test for oral and throat cancer that uses mRNA technology and an AI-powered platform, ...

My Viome results told me that I fall into the latter category of “high fermenters”. When I ask Jain what his biggest challenge has been with the launch of Viome he tells me, ...

Viome is also on track to meet its expected goal of $100 million in revenue next year, said Jain. The company also recently paired up with Nordstrom , which has plans to sell Viome kits.

Viome founder and CEO Naveen Jain said the Bellevue-based company has about 125 employees with the acquisition, though "less than a handful" of Naring Health's employees will join Viome.

Viome Inc., a provider of home-based kits that help users analyze their gut health, has raised $15 million in Series A funding. Khosla Ventures led the round, with participation from Bold Capital ...